Financials
- Market Capitalization 5.28 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-131.76
ratio cours/chiffre d'affaires
6.95
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1239 | BLTE Belite Bio Inc - American Depositary Shares | 149.47 USD | +1.90% | -1.81% | +9.78% | +140.31% | 5.88 B USD | ||
| 1285 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 99.91 USD | -1.35% | +1.14% | +26.48% | +404.09% | 5.46 B USD | ||
| 1351 | DFTX Definium Therapeutics, Inc. - Common Shares | 45.66 USD | -0.70% | +0.93% | +89.15% | +202.18% | 4.98 B USD | ||
| 1356 | CRSP CRISPR Therapeutics AG - Common Shares | 51.37 USD | +1.80% | -13.28% | -2.80% | -8.02% | 4.95 B USD |